Advertisement

Topics

Advanced Vision Therapies, Inc Company Profile

06:38 EST 25th November 2017 | BioPortfolio

Advanced Vision Therapies, Inc. (AVT) is focused on the treatment of sight-threatening eye diseases, such as age-related macular degeneration and finding a cure that works. The market, which is of a multi-billion dollar magnitude, and represents significant unmet medical needs, has been underserved by large pharma. Recent clinical trial data suggest that these diseases will be treatable, but with therapeutics that must be repeatedly injected directly into the eyes. AVT recognized that an improved delivery system is required to enable the broad application of ocular therapeutics. The company has identified two novel therapeutics and developed a proprietary delivery system, which, with a single administration, will provide sustained, possibly life-long therapy. The AVT business model is to leverage its expertise and that of its collaborators to rapidly advance its first product candidate into the clinic and then form a partnership with large pharma for late stage clinical trials, product launch, and marketing.

Location

9700 Great Seneca Highway
Rockville
Maryland
20850
United States of America

Contact

Phone: 240-453-8478
Fax: 240-453-6208
Email: mike.kaleko@avtxinc.com


News Articles [758 Associated News Articles listed on BioPortfolio]

Laying the foundation for a lifetime of eye health

After life itself, it is said that God’s great gift is vision. 80 percent of what we learn is through vision. Babies are not born with perfect vision. They develop vision over time. A child who neve...

EBE and EFPIA call for improved transparency on exemptions for advanced therapies

The European Biopharmaceutical Enterprises (EBE) and European Federation of Pharmaceutical Industries and Associations (EFPIA) have issued a statement calling on the EC to improve transparency on hosp...

Pixium Vision (PIX) - Pixium cleared to start EU Prima feasibility study

Edison Investment Research - Pharmaceutical & healthcare - Pixium Vision: Pixium has received clearance from the French regulatory agency (Agence Nationale de Sécurité du Médicame...

Scientists discover new non-genetic cause of resistance to anti-cancer therapies

The targeted anti-cancer therapies cetuximab and panitumumab are mainstays of treatment for advanced colorectal cancer, the second leading cause of cancer-related deaths in the United States.

Ultragenyx Offers $138M for Dimension Therapeutics, as Bidding War with Regenxbio Looms

Ultragenyx Pharmaceutical today proposed to acquire Dimension Therapeutics for approximately $138 million—nearly two-thirds above the price offered by Regenxbio last month—setting up a potential b...

Eye in the sky offers clearest vision of Earth

The world’s latest carbon-monitoring satellite has advanced our understanding of how the planet functions. US politicians should take note.

4 M€ de plus pour Pixium Vision

Tous les jours un bref écho des principales infos de la veille pour les biotechs francophones avec le remindHIER de BiotechFinances.  Pixium Vision (FR0011950641 – PIX), systèmes de vision ...

Patient gets ‘bionic eye’ vision system during retinal implant

More than two decades ago, doctors could do nothing for Walfre Lopez as his vision faded away due to a degenerative eye disease. Now, a revolutionary artificial-vision procedure done at University of ...

PubMed Articles [1877 Associated PubMed Articles listed on BioPortfolio]

Clinical Decision Support to Effeciently Identify Patients Eligible for Advanced Heart Failure Therapies.

Patients who need and receive timely advanced heart failure (HF) therapies have better long-term survival. However, many of these patients are not identified and referred as soon as possible.

Advanced Therapies in Venous Thromboembolism.

Advanced therapies are available for both deep venous thrombosis and pulmonary embolism when anticoagulation alone is not sufficient to improve clinical outcomes. In some cases, clinical deterioration...

Understanding current therapies in metastatic melanoma.

Cutaneous melanoma is a highly aggressive tumor developing from melanocytes, its incidence is increasing, and prognosis in advanced stages is daunting. New therapies have been approved during the rece...

A network meta-analysis of the sequencing and types of systemic therapies with definitive radiotherapy in locally advanced squamous cell carcinoma of the head and neck (LASCCHN)☆.

The current standard therapy for locally advanced squamous cell carcinoma of the head and neck (LASCCHN) is platinum-based chemotherapy plus concurrent radiotherapy (CRT), but several systemic therapi...

Detection of Early Loss of Color Vision in Age-Related Macular Degeneration - With Emphasis on Drusen and Reticular Pseudodrusen.

To evaluate chromatic sensitivity in patients with age-related macular degeneration (AMD) characterized by drusen and reticular pseudodrusen. To investigate whether the severity of color vision loss c...

Clinical Trials [5920 Associated Clinical Trials listed on BioPortfolio]

Low-vision Rehabilitation Program for Low-vision Patients and Care Givers

To evaluate health related quality of life (HRQoL) of low-vision patients and their care givers undergoing low-vision rehabilitation program (LVRP).

Low Vision Intervention Trial II (LOVIT II)

This study will determine if the interdisciplinary team low vision rehabilitation program is more effective than basic low vision care provided by an optometrist working alone in improving...

Safety Study Looking at the Effects of Stendra on Vision

The purpose of this study is to see if Stendra causes any changes in vision, eye pressure, pupil dilation, and color vision in healthy males.

Electro-acupuncture and Transcorneal Electrical Stimulation (TES) for the Treatment of Vision Loss Due to Retinitis Pigmentosa

Retinitis pigmentosa (RP) is a slowly progressive retinal degeneration for which there is no proven treatment. Patients are interested in trying alternative therapies to try to reduce thei...

VA Low Vision Intervention Trial

The primary purpose of this research study is to evaluate the effectiveness of a new outpatient low vision rehabilitation program that is targeted to serve legally blind veterans with cent...

Companies [2263 Associated Companies listed on BioPortfolio]

Xcovery Vision

Xcovery Vision is an ophthalmology-focused subsidiary of Xcovery Holding, a clinical-stage company developing novel therapies for cancer and inflammatory diseases. Xcovery Vision'...

RetroSense Therapeutics

RetroSense Therapeutics is a biotechnology company developing a game-changing gene therapy to restore vision in patients suffering from blindness due to retinitis pigmentosa (RP) ...

RetroSense Therapeutics, LLC

RetroSense Therapeutics is a privately-held biotechnology company developing life-enhancing gene therapies designed to restore vision in patients suffering from blindness due to r...

Carl Zeiss Vision

Carl Zeiss Vision (www.vision.zeiss.com) is a global leader in precision optics. With a full line of advanced customized lenses, advanced performance coatings, i.Scription® by ...

Advanced Vision Therapies, Inc

Advanced Vision Therapies, Inc. (AVT) is focused on the treatment of sight-threatening eye diseases, such as age-related macular degeneration and finding a cure that works. The market, which is of a m...

More Information about "Advanced Vision Therapies, Inc" on BioPortfolio

We have published hundreds of Advanced Vision Therapies, Inc news stories on BioPortfolio along with dozens of Advanced Vision Therapies, Inc Clinical Trials and PubMed Articles about Advanced Vision Therapies, Inc for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Advanced Vision Therapies, Inc Companies in our database. You can also find out about relevant Advanced Vision Therapies, Inc Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topic

Clincial Trials
In a clinical trial or interventional study, participants receive specific interventions according to the research plan or protocol created by the investigators. These interventions may be medical products, such as drugs or devices; procedures; or change...


Corporate Database Quicklinks



Searches Linking to this Company Record